knowledge -WSS

knowledge

author：hotspot 2025-09-10 09:08:10 - browse：73978

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： CDC advisers recommend seasonal use of Pfizer RSV shot

WSS

Why are Kaiser Permanente staff considering a strike?

A cyberattack has disrupted hospitals and health care in several states

How Vertex's cystic fibrosis drug is changing patients' lives

CDC advisers recommend seasonal use of Pfizer RSV shot

What Congress can do to address the rural doctor shortage

Biden calls for immediate release of Niger's president amid apparent coup

entertainment

knowledge

explore

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

2 US Navy sailors arrested for allegedly spying for China

State Dept. review finds Biden bears some blame for Afghanistan failures

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Hearing on Medicare drug price negotiation gets unusually heated

BioMarin wins approval for gene therapy to treat hemophilia A

Thermo Fisher plant for manufacturing gene therapies to expand

Duchenne breakthrough therapy leaves behind pioneering families

Intarcia’s device

leisure time

What Congress can do to address the rural doctor shortage

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

FDA panel to weigh approval of NurOwn, controversial ALS drug

What the cancer research community can learn from the Covid response

Attacks on the drug industry will lead to fewer breakthroughs

Drug for rare kidney disease narrowly misses mark in clinical trial

focus

entertainment

leisure time

Wikipedia